Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbo Du

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Ethnopharmacology|January 23, 2025
Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese medicineShihao Zheng, Tianyu Xue, Chengyuan Xue, et al.
Frontiers in Pharmacology|September 22, 2022
Network pharmacology and <i>in vitro</i> experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinomaXu Cao, Hening Chen, Zhiguo Li, et al.
Therapeutic Advances in Gastroenterology|November 5, 2020
Berberine for diarrhea in children and adults: a systematic review and meta-analysisMingkun Yu, Xuejing Jin, Changhao Liang, et al.
Scientific Reports|February 18, 2024
Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathyPeng Zhang, Danan Gan, Xiaoling Chi, et al.
Frontiers in Medicine|June 21, 2021
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase LevelsXiaoke Li, Yufeng Xing, Daqiao Zhou, et al.
Hepatology International|October 31, 2020
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trialXiaoke Li, Daqiao Zhou, Xiaoling Chi, et al.
Trials|August 14, 2020
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in ChinaXiaoke Li, Ludan Zhang, Mei Qiu, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Ethnopharmacology|January 23, 2025
Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese medicineShihao Zheng, Tianyu Xue, Chengyuan Xue, et al.
Frontiers in Pharmacology|September 22, 2022
Network pharmacology and <i>in vitro</i> experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinomaXu Cao, Hening Chen, Zhiguo Li, et al.
Therapeutic Advances in Gastroenterology|November 5, 2020
Berberine for diarrhea in children and adults: a systematic review and meta-analysisMingkun Yu, Xuejing Jin, Changhao Liang, et al.
Scientific Reports|February 18, 2024
Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathyPeng Zhang, Danan Gan, Xiaoling Chi, et al.
Frontiers in Medicine|June 21, 2021
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase LevelsXiaoke Li, Yufeng Xing, Daqiao Zhou, et al.
Hepatology International|October 31, 2020
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trialXiaoke Li, Daqiao Zhou, Xiaoling Chi, et al.
Trials|August 14, 2020
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in ChinaXiaoke Li, Ludan Zhang, Mei Qiu, et al.
Pageof 7